<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: We sought to determine risk models for predicting early and late <z:hpo ids='HP_0001297'>stroke</z:hpo> in a large cohort of high-risk post-<z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (MI) patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS AND RESULTS: We prospectively analysed data from 14 703 patients in the VALIANT trial with <z:hpo ids='HP_0011009'>acute</z:hpo> MI complicated by <z:hpo ids='HP_0001635'>heart failure</z:hpo>, left ventricular (LV) systolic dysfunction, or both </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were randomized 0.5-10 days after <z:hpo ids='HP_0011009'>acute</z:hpo> MI to <z:chebi fb="0" ids="9927">valsartan</z:chebi>, <z:chebi fb="0" ids="3380">captopril</z:chebi>, or their combination </plain></SENT>
<SENT sid="3" pm="."><plain>We evaluated risk factors for early (&lt;45 days) and late (&gt;45 days) <z:hpo ids='HP_0001297'>stroke</z:hpo> by using multivariable Cox proportional hazards regression analyses with stepwise variable selection techniques applied to 92 pre-specified potential predictor variables </plain></SENT>
<SENT sid="4" pm="."><plain>After randomization, 463 (3.2%) patients had fatal (n = 124) or non-fatal (n = 339) <z:hpo ids='HP_0001297'>strokes</z:hpo>, with 134 <z:hpo ids='HP_0001297'>strokes</z:hpo> occurring in the first 45 days </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:hpo ids='HP_0001297'>strokes</z:hpo> were classified as ischaemic (348), haemorrhagic (40), or of indeterminate cause (75) </plain></SENT>
<SENT sid="6" pm="."><plain>Estimated glomerular filtration rate and heart rate when in sinus rhythm were the most powerful predictors of early <z:hpo ids='HP_0001297'>stroke</z:hpo> (&lt;45 days after MI), whereas diastolic blood pressure (<z:chebi fb="4" ids="35861">DBP</z:chebi>) &gt;90 mmHg, prior <z:hpo ids='HP_0001297'>stroke</z:hpo>, and <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) were the most powerful predictors of <z:hpo ids='HP_0001297'>stroke</z:hpo> overall </plain></SENT>
<SENT sid="7" pm="."><plain>Ejection fraction and sex were not predictive of <z:hpo ids='HP_0001297'>stroke</z:hpo> in this cohort </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Among high-risk patients presenting with MI but without initial neurological symptoms, the risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> 6 weeks thereafter is 0.94% (95% CI 0.78-1.09) </plain></SENT>
<SENT sid="9" pm="."><plain>Of the most powerful baseline predictors of <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:chebi fb="4" ids="35861">DBP</z:chebi> and AF are amenable to therapeutic interventions and thus merit special attention in these patients </plain></SENT>
</text></document>